TRPV4 and prostate carcinoma: For lung cancer and prostate cancer, the expression levels of TRPV4 in tumor-derived endothelial cells are lower than those of normal endothelial cells, thus elevating the sensitivity of endothelial cells to extracellular matrix stiffness and being conducive to the formation of abnormal blood vessels29.